D.E. Shaw & Co’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$103K Sell
2022
Q3
$415K Sell
2022
Q2
$1.26M Sell
2022
Q1
$2.48M Buy
2021
Q4
$3.33M Sell
2021
Q3
$5.96M Buy
2021
Q2
$5.68M Buy
2021
Q1
$1.43M Buy
2020
Q4
$126K Buy
2017
Q4
Sell
2017
Q3
$251K Buy